5 nov 2019
CPhI Worldwide 2019
ATABAY

ATABAY

Exhibitor at CPhI Worldwide 2019 stand 42C21, API

About us

ATABAY Group of companies: A leader in the production of Paracetamol (Acetaminophen) powder and direct compression grades in its FDA USA-approved and EU, back integrated and dedicated cGMP plant. Back integration covers production of p-aminophenol which is acetylated to Paracetamol and re-crystallized with water as solvent.

Products conform to the current BP, USP, PH EUR pharmacopeias and has COS from EDQM.

Atabay provdies an injectable form of Paracetamol and produces a wide-range of pharmaceutical drugs such as beta-lactam antibiotics, analgesics, antirheumatics, antituberculosis products in tablets, suppositories, syrup, suspension, cream/ointment and sachet dosage forms. Atabay is currently developing generic antiviral drugs with in-house synthesized APIs.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; North America; Africa; Central/South America
Affiliated categories: API Contract Manufacturing |Intermediates, Fine and Specialty Chemicals More

Products featured at CPhI Worldwide 2019

ATABAY

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 42C21